tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ANNX Stock Latest News

Annexon initiated with a Buy at Clear Street
The FlyAnnexon initiated with a Buy at Clear Street
11d ago
ANNX
Annexon price target raised to $27 from $14 at Wells Fargo
PremiumThe Fly
Annexon price target raised to $27 from $14 at Wells Fargo
23d ago
ANNX
Annexon price target lowered to $8 from $9 at BofA
PremiumThe Fly
Annexon price target lowered to $8 from $9 at BofA
25d ago
ANNX
Annexon price target lowered to $8 from $9 at BofA
PremiumThe Fly
Annexon price target lowered to $8 from $9 at BofA
26d ago
ANNX
Annexon Biosciences Completes Successful Public Offering
PremiumCompany Announcements
Annexon Biosciences Completes Successful Public Offering
28d ago
8K
ANNX
Annexon 25.1M share Spot Secondary priced at $2.60
PremiumThe FlyAnnexon 25.1M share Spot Secondary priced at $2.60
30d ago
ANNX
Annexon announces $75M common stock, warrants offering
Premium
The Fly
Annexon announces $75M common stock, warrants offering
30d ago
ANNX
Annexon Biosciences: Promising Advancements in Late-Stage Complement Inhibitors Drive Buy Rating
Premium
Ratings
Annexon Biosciences: Promising Advancements in Late-Stage Complement Inhibitors Drive Buy Rating
1M ago
ANNX
Positive Investment Outlook for Annexon Biosciences Driven by Financial Stability and Key Pipeline Developments
PremiumRatings
Positive Investment Outlook for Annexon Biosciences Driven by Financial Stability and Key Pipeline Developments
1M ago
ANNX
Annexon Biosciences Reports Increased R&D Expenses
PremiumCompany Announcements
Annexon Biosciences Reports Increased R&D Expenses
1M ago
ANNX
Annexon reports Q3 EPS (37c), consensus (34c)
PremiumThe Fly
Annexon reports Q3 EPS (37c), consensus (34c)
1M ago
ANNX
ANNX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ANNX Upcoming Earnings Report: What to Expect?
1M ago
ANNX
Annexon Biosciences’ New Study on Tanruprubart for Guillain-Barré Syndrome: A Potential Game-Changer?
PremiumCompany AnnouncementsAnnexon Biosciences’ New Study on Tanruprubart for Guillain-Barré Syndrome: A Potential Game-Changer?
2M ago
ANNX
Annexon Biosciences Advances AMD Treatment with ANX007 Study
Premium
Company Announcements
Annexon Biosciences Advances AMD Treatment with ANX007 Study
2M ago
ANNX
Annexon participates in a conference call with JPMorgan
Premium
The Fly
Annexon participates in a conference call with JPMorgan
3M ago
ANNX
Annexon Biosciences Faces Financial Risks Amid Global Trade Challenges
PremiumCompany Announcements
Annexon Biosciences Faces Financial Risks Amid Global Trade Challenges
4M ago
ANNX
Promising Outlook for Annexon Biosciences: Buy Rating Backed by Strong Pipeline and Financial Stability
PremiumRatings
Promising Outlook for Annexon Biosciences: Buy Rating Backed by Strong Pipeline and Financial Stability
4M ago
ANNX
Annexon Biosciences Reports Q2 2025 Financial Results
PremiumCompany Announcements
Annexon Biosciences Reports Q2 2025 Financial Results
4M ago
ANNX
Annexon reports Q2 EPS (34c), consensus (36c)
PremiumThe Fly
Annexon reports Q2 EPS (34c), consensus (36c)
4M ago
ANNX
Annexon reports Q2 EPS (34c), consensus (36c)
PremiumThe FlyAnnexon reports Q2 EPS (34c), consensus (36c)
4M ago
ANNX
Annexon completes enrollment in Phase 3 ARCHER II trial
Premium
The Fly
Annexon completes enrollment in Phase 3 ARCHER II trial
5M ago
ANNX
Annexon tells Wells Fargo doctor tweet not factural
Premium
The Fly
Annexon tells Wells Fargo doctor tweet not factural
5M ago
ANNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >